Search

Displaying results 9721 - 9730 of 10000 in total
  1. Drug

    Fluocinolone

    go.drugbank.com/drugs/DB12553
    Investigational

    Fluocinolone has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Choroidal Neovascularization.

  2. Drug

    Samatasvir

    go.drugbank.com/drugs/DB12660
    Investigational

    Samatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.

  3. Drug

    Naptumomab estafenatox

    go.drugbank.com/drugs/DB12807
    Investigational

    Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.

  4. Drug

    Pyroxamide

    go.drugbank.com/drugs/DB12847
    Investigational

    Pyroxamide has been used in trials studying the treatment of Leukemia, Lymphoma, Small Intestine Cancer, Precancerous Condition, and Myelodysplastic Syndromes, among others.

  5. Drug

    Ombrabulin

    go.drugbank.com/drugs/DB12882
    Investigational

    Ombrabulin has been used in trials studying the treatment of Sarcoma, Neoplasms, Solid Tumor, Neoplasms, Malignant, and Advanced Solid Tumors, among others.

  6. Drug

    Samarium Sm-153

    go.drugbank.com/drugs/DB12905
    Investigational

    Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer.

  7. Drug

    REP8839

    go.drugbank.com/drugs/DB05224
    Experimental

    REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).

  8. Drug

    2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

    go.drugbank.com/drugs/DB08398
    Investigational

    PhIP (2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine) has been used in trials studying the basic science of Pancreas Cancer.

  9. Drug

    Parathyroid Hormone-Related Protein 1-36

    go.drugbank.com/drugs/DB16278
    Investigational

    Parathyroid Hormone-Related Protein 1-36 is under investigation in clinical trial NCT00853723 (Comparison Study of Pthrp and PTH to Treat Osteoporosis).

  10. Drug

    E1v1.11

    go.drugbank.com/drugs/DB18363
    Experimental

    E1v1.11 is an antisense oligonucleotide targeting the _SMN2_ gene which is under investigation for the treatment of spinal muscular atrophy (SMA).[L48196]